Market

Replimune stock plunges after FDA cancer drug rejection details emerge

Replimune stock plunges after FDA cancer drug rejection details emerge
Read More

Related Posts

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

DeNinno, Wabtec exec VP, sells $1.07 million in WAB stock

Mendonca, Wabtec president, sells $433k in WAB stock

Mendonca, Wabtec president, sells $433k in WAB stock

Empire State Realty Trust declares Q4 dividend of $0.035 per share

Empire State Realty Trust declares Q4 dividend of $0.03...

Form 144 eToro Group Ltd For: 5 December

Form 144 eToro Group Ltd For: 5 December

US Treasury Secretary Bessent holds constructive call with China

US Treasury Secretary Bessent holds constructive call w...

‘Soon, all commodity charts will look like gold.’ BofA’s Hartnett goes bullish on commodities.

‘Soon, all commodity charts will look like gold.’ BofA’...